The third key question is whether CX3CR1 pathogenic variants detected in autism spectrum disorder, schizophrenia, and multiple sclerosis (reviewed in Watson et al., 2020) contribute to disease pathogenesis via aberrant FKN-CX3CR1 signaling in precursor cells. This evidence concerns the gene CX3CR1 and autism spectrum disorder.